1. CoreAge Rx Time Out — sponsored first placement
Time Out lists estriol 0.3%, vitamin C 5% and hydrolyzed hyaluronic acid 0.5%, with a $576 twelve-month plan behind the advertised $48 monthly rate. Shorter plans list $330 for six months, $189 for three months and $75 for one month. No auto-billing is advertised. The public offer describes an online questionnaire and clinician review. The September 27, 2026 recheck confirms a dedicated link to the current Time Out sales page and expanded descriptions of ingredient roles and hormone precautions. Its appearance claims remain distinct from a study of the finished combination.
The strengths do not establish that the finished product outperforms another cream. Confirm the dispensed quantity, actual order charge, refill schedule and complete ingredients. Our CoreAge Rx review distinguishes the advertised offer from what needs to be established during prescribing. This first position remains sponsored regardless of those answers.
For a useful comparison, decide whether combining several ingredients is a priority or whether you want to discuss each element separately. A three-ingredient preparation can still require attention to the rest of a routine, especially when other active products are already prescribed. Convenience and clinical suitability are different criteria.
2. Alloy M4 Face Cream Rx
Alloy M4 displayed $150 for a three-month supply at our September 26, 2026 check. Confirm the current cream strength. The study tested 0.3%. Alloy also makes a product-related study report publicly available, which is useful material for a clinician discussion rather than a reason to assume a result is guaranteed.
Its $50 monthly equivalent should stay attached to the three-month purchase context. Ask about renewal and cancellation, and confirm which M4 product is being offered. Our Alloy review examines the difference between reported study findings, larger marketing claims and the unanswered questions for a particular patient.
3. Musely The Aging Repair Cream
Musely showed $36/month with two-month auto-refill and $103 once on September 26, 2026. The November 11 page instead advertises $37/month or $107 once; confirm the first charge. Its product page highlights estriol, hyaluronic acid and aloe, with the prescribing clinician selecting a formula. Obtain the exact prescription details instead of assuming that every patient receives an identical preparation.
The page’s reported improvement percentages are described as self-reported patient outcomes. That is a different form of evidence from a controlled trial. The Musely review also addresses the conditions attached to its refund offer, which should be read before using it as a purchasing criterion.
4. Midi Estriol+ Face Cream
Midi listed $149 for a 90-day supply totaling 90 mL. Its description names estriol, DMAE and hyaluronic acid. The Midi review now covers documented strengths; confirm the complete preparation you would receive.
The online review pathway is part of the product offer, but should not be assumed to include all of Midi’s wider menopause-care services. Our Midi review looks at the available purchase information, the timing estimates on its pages and the evidence questions left open by testimonials and ingredient explanations.
Compare money on the same basis
A fair budget comparison includes the first charge, expected subsequent charges and the amount supplied. It also records whether a figure is a starting price, a supply price or a monthly equivalent. Putting only the smallest number from each site in a column would obscure the terms that affect an actual purchase.
Even with those fields aligned, a cost calculation cannot establish equivalent value. The prescribed formula, access to follow-up and your clinician’s assessment may differ. Use the comparison desk to switch between price, formula, access and evidence; then request written confirmation of the details that matter before submitting payment.
A low-cost plan that you cannot use appropriately is not a useful bargain. Likewise, a higher price is not proof of better compounding quality or better medical outcomes. Ask how the dispensing pharmacy is identified, how a concern is reported and what happens if the proposed plan changes after evaluation.
Read “best” within the evidence
The FDA’s menopause guidance says there are no FDA-approved estriol drugs. All the comparative shopping detail above sits within that regulatory context. Our FDA article explains why prescription access, compounding and approval are separate issues.
The research guide addresses another limit: ingredient studies and product studies cannot be freely substituted for one another. Evidence from a short trial does not settle long-term safety or demonstrate that one of these commercial products is superior to all the others. We have not identified a direct head-to-head trial supporting such a ranking.
There are sensible questions beyond estriol too. The American Academy of Dermatology discusses moisturization, sun protection and assessment of menopausal skin changes. A prescription purchase need not be the first or only response to a new concern.
Choose the next conversation
Use this list to narrow what needs clarification, then take those questions to a qualified clinician. The consultation sheet lets you save a short set covering formula, hormone exposure, cost and follow-up. It asks for no medical history and does not recommend a prescription.
The most useful result of a comparison is knowing what evidence applies, what remains uncertain and what the complete plan would involve. CoreAge Rx retains its disclosed sponsored first position here. Your treatment decision belongs to an individual clinical conversation, which may lead to a different product or to no estriol prescription at all.
This four-cream comparison is now accompanied by a separate M4 Face Serum review. Its current $159 three-month offer describes a different preparation. Its product data now state ingredient strengths; the cream-specific results still do not establish a serum trial. It is not another independently ranked provider.